Integra LifeSciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IART and other ETFs, options, and stocks.

About IART

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. 

CEO
Stuart M. Essig
CEOStuart M. Essig
Employees
4,427
Employees4,427
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1989
Founded1989
Employees
4,427
Employees4,427

IART Key Statistics

Market cap
1.10B
Market cap1.10B
Price-Earnings ratio
-2.18
Price-Earnings ratio-2.18
Dividend yield
Dividend yield
Average volume
1.60M
Average volume1.60M
High today
$14.39
High today$14.39
Low today
$13.98
Low today$13.98
Open price
$14.37
Open price$14.37
Volume
857.78K
Volume857.78K
52 Week high
$16.49
52 Week high$16.49
52 Week low
$8.70
52 Week low$8.70

Stock Snapshot

With a market cap of 1.1B, Integra LifeSciences(IART) trades at $14.10. The stock has a price-to-earnings ratio of -2.18.

On 2026-05-18, Integra LifeSciences(IART) stock traded between a low of $13.98 and a high of $14.39. Shares are currently priced at $14.10, which is +0.9% above the low and -2.0% below the high.

The Integra LifeSciences(IART)'s current trading volume is 857.78K, compared to an average daily volume of 1.6M.

During the past year, Integra LifeSciences(IART) stock moved between $8.70 at its lowest and $16.49 at its peak.

During the past year, Integra LifeSciences(IART) stock moved between $8.70 at its lowest and $16.49 at its peak.

IART News

Simply Wall St 9h
A Look At Integra LifeSciences Valuation After Earnings Beat And CEO Stuart Essig’s Return

Advertisement Earnings beat and leadership shift put Integra LifeSciences Holdings (IART) in focus Integra LifeSciences Holdings (IART) is back on investors’...

A Look At Integra LifeSciences Valuation After Earnings Beat And CEO Stuart Essig’s Return
Simply Wall St 2d
Will Leadership Shift and Tighter Incentives Change Integra LifeSciences Holdings' Narrative?

Integra LifeSciences Holdings recently reported first-quarter 2026 results with sales of US$391.92 million, a smaller net loss of US$4.62 million, reaffirmed fu...

Will Leadership Shift and Tighter Incentives Change Integra LifeSciences Holdings' Narrative?

Analyst ratings

50%

of 10 ratings
Buy
20%
Hold
50%
Sell
30%

People also own

Based on the portfolios of people who own IART. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.